6,175 research outputs found
Salt marsh ecosystem biogeochemical responses to nutrient enrichment: a paired N-15 tracer study
We compared processing and fate of dissolved NO3- in two New England salt marsh ecosystems, one receiving natural flood tide concentrations of similar to 1-4 mu mol NO3-/L and the other receiving experimentally fertilized flood tides containing similar to 70-100 mu mol NO3-/L. We conducted simultaneous (NO3-)-N-15 (isotope) tracer additions from 23 to 28 July 2005 in the reference (8.4 ha) and fertilized (12.4 ha) systems to compare N dynamics and fate. Two full tidal cycles were intensively studied during the paired tracer additions. Resulting mass balances showed that essentially 100% (0.48-0.61 mol NO3-N.ha(-1).h(-1)) of incoming NO3- was assimilated, dissimilated, sorbed, or sedimented (processed) within a few hours in the reference system when NO3- concentrations were 1.3-1.8 mu mol/L. In contrast, only 50-60% of incoming NO3- was processed in the fertilized system when NO3- concentrations were 84-96 mu mol/ L; the remainder was exported in ebb tidewater. Gross NO3- processing was similar to 40 times higher in the fertilized system at 19.34- 24.67 mol NO3-N.ha(-1).h(-1). Dissimilatory nitrate reduction to ammonium was evident in both systems during the first 48 h of the tracer additions but \u3c1% of incoming (NO3-)-N-15 was exported as (NH4+)-N-15. Nitrification rates calculated by (NO3-)-N-15 dilution were 6.05 and 4.46 mol.ha(-1).h(-1) in the fertilized system but could not be accurately calculated in the reference system due to rapid (\u3c4 h) NO3- turnover. Over the five-day paired tracer addition, sediments sequestered a small fraction of incoming NO3-, although the efficiency of sequestration was 3.8% in the reference system and 0.7% in the fertilized system. Gross sediment N sequestration rates were similar at 13.5 and 12.6 mol.ha(-1).d(-1), respectively. Macrophyte NO3- uptake efficiency, based on tracer incorporation in aboveground tissues, was considerably higher in the reference system (16.8%) than the fertilized system (2.6%), although bulk uptake of NO3- by plants was lower in the reference system (1.75 mol NO3-.ha(-1).d(-1)) than the fertilized system (similar to 10 mol NO3-.ha(-1).d(-1)). Nitrogen processing efficiency decreased with NO3- load in all pools, suggesting that the nutrient processing capacity of the marsh ecosystem was exceeded in the fertilized marsh
The Black Hole Mass of NGC 4151: Comparison of Reverberation Mapping and Stellar Dynamical Measurements
We present a stellar dynamical estimate of the black hole (BH) mass in the Seyfert 1 galaxy, NGC 4151. We analyze ground-based spectroscopy as well as imaging data from the ground and space, and we construct 3-integral axisymmetric models in order to constrain the BH mass and mass-to-light ratio. The dynamical models depend on the assumed inclination of the kinematic symmetry axis of the stellar bulge. In the case where the bulge is assumed to be viewed edge-on, the kinematical data give only an upper limit to the mass of the BH of ∼ 4 × 107 M⊙ (1 ). If the bulge kinematic axis is assumed to have the same inclination as the symmetry axis of the large-scale galaxy disk (i.e., 23◦ relative to the line of sight), a best-fit dynamical mass between 4 − 5 × 107 M⊙ is obtained. However, because of the poor quality of the fit when the bulge is assumed to be inclined (as determined by the noisiness of the 2 surface and its minimum value), and because we lack spectroscopic data that clearly resolves the BH sphere of influence, we consider our measurements to be tentative estimates of the dynamical BH mass. With this preliminary result, NGC 4151 is now among the small sample of galaxies in which the BH mass has been constrained from two independent techniques, and the mass values we find for both bulge inclinations are in reasonable agreement with the recent estimate from reverberation mapping (4.57+0.57 −0.47 × 107 M⊙) published by Bentz et al
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: Outcomes and biomarker analysis from the SUMMIT trial
BACKGROUND: HER2 mutations are targetable alterations in patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC). In the SUMMIT basket study, patients with HER2-mutant MBC received neratinib monotherapy, neratinib + fulvestrant, or neratinib + fulvestrant + trastuzumab (N + F + T). We report results from 71 patients with HR+, HER2-mutant MBC, including 21 (seven in each arm) from a randomized substudy of fulvestrant versus fulvestrant + trastuzumab (F + T) versus N + F + T.
PATIENTS AND METHODS: Patients with HR+ HER2-negative MBC with activating HER2 mutation(s) and prior cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy received N + F + T (oral neratinib 240 mg/day with loperamide prophylaxis, intramuscular fulvestrant 500 mg on days 1, 15, and 29 of cycle 1 then q4w, intravenous trastuzumab 8 mg/kg then 6 mg/kg q3w) or F + T or fulvestrant alone. Those whose disease progressed on F + T or fulvestrant could cross-over to N + F + T. Efficacy endpoints included investigator-assessed objective response rate (ORR), clinical benefit rate (RECIST v1.1), duration of response, and progression-free survival (PFS). Plasma and/or formalin-fixed paraffin-embedded tissue samples were collected at baseline; plasma was collected during and at end of treatment. Extracted DNA was analyzed by next-generation sequencing.
RESULTS: ORR for 57 N + F + T-treated patients was 39% [95% confidence interval (CI) 26% to 52%); median PFS was 8.3 months (95% CI 6.0-15.1 months). No responses occurred in fulvestrant- or F + T-treated patients; responses in patients crossing over to N + F + T supported the requirement for neratinib in the triplet. Responses were observed in patients with ductal and lobular histology, 1 or ≥1 HER2 mutations, and co-occurring HER3 mutations. Longitudinal circulating tumor DNA sequencing revealed acquisition of additional HER2 alterations, and mutations in genes including PIK3CA, enabling further precision targeting and possible re-response.
CONCLUSIONS: The benefit of N + F + T for HR+ HER2-mutant MBC after progression on CDK4/6is is clinically meaningful and, based on this study, N + F + T has been included in the National Comprehensive Cancer Network treatment guidelines. SUMMIT has improved our understanding of the translational implications of targeting HER2 mutations with neratinib-based therapy
Effect of Palpable Udder Defects on Milk Yield, Somatic Cell Count, and Milk Composition in Non-Dairy Ewes
(c) The Author/sPublishe
Steps Toward Determination of the Size and Structure of the Broad-Line Region in Active Galactic Nuclei. XII. Ground-Based Monitoring of 3C 390.3
Results of a ground-based optical monitoring campaign on 3C 390.3 in 1994-1995 are presented. The broadband fluxes (B, V, R, and I), the spectrophotometric optical continuum flux and the Fλ(5177 Å),integrated emission-line fluxes of Hᵪ Hβ, Hᵧ, He I λ5876 and He II λ4686 all show a nearly monotonic increase with episodes of milder short-term variations superposed. The amplitude of the continuum variations increases with decreasing wavelength (4400-9000 Å). The optical continuum variations follow the variations in the ultraviolet and X-ray with time delays, measured from the centroids of the cross-correlation functions, typically around 5 days, but with uncertainties also typically around 5 days; zero time delay between the high-energy and low-energy continuum variations cannot be ruled out. The strong optical emission lines Hᵪ Hβ, Hᵧ, He I λ5876 respond to the high-energy continuum variations with time delays typically about 20 days, with uncertainties of about 8 days. There is some evidence that He II λ4686 responds somewhat more rapidly, with a time delay of around 10 days, but again, the uncertainties are quite large (~8 days). The mean and rms spectra of the Hᵪ and Hβ line profiles provide indications for the existence of at least three distinct components located at ±4000 and 0 km s-1 relative to the line peak. The emission-line profle variations are largest near line center
Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis
Background: Randomized clinical trials (RCTs) have demonstrated the efficacy of implantable
cardioverter-defibrillators (ICDs) in reducing sudden cardiac death (SCD) in specific
patient populations. However, patients ≥ 65 years were under-represented in these trials and
the overall benefit of ICDs may be diminished in older patients due to competing risks for
death. We evaluate the published data on ICD efficacy at reducing all-cause mortality in
patients ≥ 65 years and in patients ≥ 75 years.
Methods: We searched MEDLINE to identify RCTs and observational studies of ICDs that
provided age-based outcome data for primary prevention of SCD. The primary endpoint was
mortality evaluated by a meta-analysis of the RCTs using a random-effects model. Secondary
endpoints included operative mortality, long-term complications and quality of life.
Results: The enrollment of patients ≥ 65 years in RCTs was limited (range: 33% in DEFINITE
to 56% in MUSTT). Combining data from four RCTs (n = 3,562) revealed that
primary prevention ICD therapy is efficacious in reducing all-cause mortality in patients ≥ 65 years
(HR 0.66; 95% CI 0.50–0.87; test of heterogeneity: X2 = 5.26; p = 0.15). For patients
≥ 75 years, combining data from four RCTs (n = 579) revealed that primary prevention ICD
therapy remains efficacious in reducing all-cause mortality (HR 0.73; 95% CI 0.51–0.974;
p = 0.03). There appears to be no difference in ICD-related, operative, in-hospital, or long-
-term complications among older patients compared to younger patients, although it remains
unclear if older patients have a better quality of life with an ICD than younger patients.
Conclusions: Although the overall evidence regarding ICD efficacy in patients ≥ 65 years is
limited and divergent, and the evidence available for patients ≥ 75 years is even more sparse,
our meta-analysis suggests that primary prevention ICDs may be beneficial in older patients.
Our findings need to be validated by future studies, particularly ones examining ICD complications
and quality of life. (Cardiol J 2011; 18, 5: 503–514
Potential Geographic Distribution of Brown Marmorated Stink Bug Invasion (Halyomorpha halys)
BACKGROUND: The Brown Marmorated Stink Bug (BMSB), Halyomorpha halys (Stål) (Hemiptera: Pentatomidae), native to Asia, is becoming an invasive species with a rapidly expanding range in North America and Europe. In the US, it is a household pest and also caused unprecedented damage to agriculture crops. Exploring its climatic limits and estimating its potential geographic distribution can provide critical information for management strategies. METHODOLOGY/PRINCIPALS: We used direct climate comparisons to explore the climatic niche occupied by native and invasive populations of BMSB. Ecological niche modelings based on the native range were used to anticipate the potential distribution of BMSB worldwide. Conversely, niche models based on the introduced range were used to locate the original invasive propagates in Asia. Areas with high invasion potential were identified by two niche modeling algorithms (i.e., Maxent and GARP). CONCLUSIONS/SIGNIFICANCE: Reduced dimensionality of environmental space improves native model transferability in the invade area. Projecting models from invasive population back to native distributional areas offers valuable information on the potential source regions of the invasive populations. Our models anticipated successfully the current disjunct distribution of BMSB in the US. The original propagates are hypothesized to have come from northern Japan or western Korea. High climate suitable areas at risk of invasion include latitudes between 30°-50° including northern Europe, northeastern North America, southern Australia and the North Island of New Zealand. Angola in Africa and Uruguay in South America also showed high climate suitability
The novel E. coli cell division protein, YtfB, plays a role in eukaryotic cell adhesion.
Characterisation of protein function based solely on homology searches may overlook functions under specific environmental conditions, or the possibility of a protein having multiple roles. In this study we investigated the role of YtfB, a protein originally identified in a genome-wide screen to cause inhibition of cell division, and has demonstrated to localise to the Escherichia coli division site with some degree of glycan specificity. Interestingly, YtfB also shows homology to the virulence factor OapA from Haemophilus influenzae, which is important for adherence to epithelial cells, indicating the potential of additional function(s) for YtfB. Here we show that E. coli YtfB binds to N'acetylglucosamine and mannobiose glycans with high affinity. The loss of ytfB results in a reduction in the ability of the uropathogenic E. coli strain UTI89 to adhere to human kidney cells, but not to bladder cells, suggesting a specific role in the initial adherence stage of ascending urinary tract infections. Taken together, our results suggest a role for YtfB in adhesion to specific eukaryotic cells, which may be additional, or complementary, to its role in cell division. This study highlights the importance of understanding the possible multiple functions of proteins based on homology, which may be specific to different environmental conditions
Species' geographic distributions through time: Playing catchup with changing climates
This is the author's accepted manuscript.Species’ ranges are often treated as a rather fixed characteristic, rather than a fluid, ever-changing manifestation of their ecological requirements and dispersal abilities. Paleontologists generally have had a more flexible point of view on this issue than neontologists, but each perspective can improve by appreciating the other. Here, we provide an overview of paleontological and neontological perspectives on species’ geographic distributions, focusing on what can be learned about historical variations in distributions. The cross-disciplinary view, we hope, offers some novel perspectives on species-level biogeography
- …